Insider Selling: LifeStance Health Group (NASDAQ:LFST) CTO Sells $541,402.29 in Stock

Key Points

• LifeStance’s CTO sold 42,067 shares for approximately $541,402 at an average price of $12.87, reducing his direct ownership by 17% to 205,379 shares. He also sold 44,394 shares in August.
• LFST shares traded at $12.73, near their 52-week high of $13.15, with a market capitalization of about $4.94 billion. The stock’s average analyst rating is “Moderate Buy”, with a $12.38 average price target.
• LifeStance reported quarterly revenue of $435.35 million, up 26.1% year over year, and earnings of $0.06 per share—beating the $0.03 consensus estimate.

LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) CTO Vukasin Paunovich sold 42,067 shares of the business's stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $12.87, for a total transaction of $541,402.29. Following the sale, the chief technology officer directly owned 205,379 shares in the company, valued at $2,643,227.73. This trade represents a 17.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Vukasin Paunovich also recently made the following trade(s):

• On Monday, August 10th, Vukasin Paunovich sold 44,394 shares of LifeStance Health Group stock. The stock was sold at an average price of $10.85, for a total value of $481,674.90.

LifeStance Health Group Stock Performance

Shares of LFST stock traded down $0.10 during mid-day trading on Friday, reaching $12.73. The stock had a trading volume of 2,043,233 shares, compared to its average volume of 3,445,051. LifeStance Health Group, Inc. has a 1-year low of $4.77 and a 1-year high of $13.15. The firm has a market cap of $4.94 billion, a price-to-earnings ratio of 97.93 and a beta of 1.22. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.18. The business's fifty day moving average is $11.44 and its 200-day moving average is $8.77.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.03. LifeStance Health Group had a net margin of 3.19% and a return on equity of 3.39%. The company had revenue of $435.35 million for the quarter, compared to the consensus estimate of $414.58 million. During the same quarter in the prior year, the company earned ($0.01) EPS. LifeStance Health Group's quarterly revenue was up 26.1% on a year-over-year basis. On average, research analysts forecast that LifeStance Health Group, Inc. will post 0.16 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. Barclays increased their price target on LifeStance Health Group from $9.00 to $13.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 14th. Weiss Ratings upgraded LifeStance Health Group from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, August 11th. Wall Street Zen raised LifeStance Health Group from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 15th. Canaccord Genuity Group lifted their price target on LifeStance Health Group from $11.00 to $13.00 and gave the company a "buy" rating in a research report on Tuesday, July 21st. Finally, KeyCorp upped their price objective on LifeStance Health Group from $11.00 to $13.00 and gave the stock an "overweight" rating in a research report on Monday, July 13th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $12.38.

Institutional Trading of LifeStance Health Group

Institutional investors have recently bought and sold shares of the business. Larson Financial Group LLC raised its stake in shares of LifeStance Health Group by 19,952.6% during the 4th quarter. Larson Financial Group LLC now owns 3,810 shares of the company's stock worth $27,000 after buying an additional 3,791 shares during the period. KBC Group NV purchased a new stake in LifeStance Health Group in the 1st quarter worth $29,000. EverSource Wealth Advisors LLC raised its position in LifeStance Health Group by 359.1% during the first quarter. EverSource Wealth Advisors LLC now owns 6,909 shares of the company's stock worth $44,000 after acquiring an additional 5,404 shares during the period. Bayesian Capital Management LP purchased a new position in LifeStance Health Group during the second quarter valued at $52,000. Finally, PNC Financial Services Group Inc. grew its position in shares of LifeStance Health Group by 615.3% in the first quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company's stock valued at $59,000 after purchasing an additional 7,987 shares during the period. 85.50% of the stock is owned by institutional investors and hedge funds.

About LifeStance Health Group

LifeStance Health Group NASDAQ: LFST is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source